BioNTech SE (BNTX) said Monday that it plans to establish its Regional Headquarters for south east Asia in Singapore.
The company also said it plans to establish a fully integrated mRNA manufacturing facility in Singapore with support from the Singapore Economic Development Board. The new facility will provide regional and global supply capacity of BioNTech's mRNA-based product candidates, as well as a rapid response production capability for south east Asia to address potential pandemic threats.
The company noted that it plans to open its Singapore office and initiate construction of the manufacturing facility in 2021.
The company anticipates that the site could be operational as early as 2023 and will create up to 80 jobs in Singapore.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.